Beta Bionics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $35,505 | $32,013 | $27,626 | $32,121 |
Gross Profit | 20,331 | 18,902 | 16,437 | 18,944 |
EBITDA | -25,302 | -24,460 | -20,908 | -12,530 |
EBIT | -26,609 | -25,578 | -21,895 | -13,465 |
Net Income | -24,353 | -23,403 | -21,895 | -13,466 |
Net Change In Cash | 35,505 | 32,013 | 27,626 | 32,121 |
Free Cash Flow | -14,562 | -15,661 | -25,209 | -10,530 |
Cash | 81,551 | 44,318 | 30,206 | 31,576 |
Basic Shares | 46,541 | 44,545 | 44,436 | 40,529 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $100,251 | $65,124 | $11,995 | $179 |
Gross Profit | 55,537 | 35,888 | 6,308 | 179 |
EBITDA | -70,324 | -52,473 | -42,008 | -62,657 |
EBIT | -73,199 | -54,756 | -44,099 | -64,744 |
Net Income | -73,200 | -54,756 | -44,099 | -64,751 |
Net Change In Cash | 100,251 | 65,124 | 11,995 | 179 |
Free Cash Flow | -56,222 | -51,668 | -32,847 | -60,980 |
Cash | 31,576 | 30,432 | 26,566 | 27,675 |
Basic Shares | 40,529 | 42,859 | 42,859 | 42,859 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.52 |
2026-06-30 | -$0.53 |
2026-03-31 | -$0.36 |
2025-12-31 | -$0.30 |